期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | MOLECULAR IMAGING AND BIOLOGY LetPub Score 6.3
50 ratings
Rate
Reputation 7.6 Influence 5.1 Speed 7.0 | ||||||||||||||||||||||||
期刊簡稱 | MOL IMAGING BIOL | ||||||||||||||||||||||||
ISSN | 1536-1632 | ||||||||||||||||||||||||
E-ISSN | 1860-2002 | ||||||||||||||||||||||||
h-index | 63 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 3.30%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | https://www.springer.com/11307 | ||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/mibi/default.aspx | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | Springer International Publishing | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||||||
創刊年 | 2005 | ||||||||||||||||||||||||
每年文章數 | 84每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 35.99% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1536-1632%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: About 3.0 month(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Ordinary | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[MOLECULAR IMAGING AND BIOLOGY] 的評論 | 撰寫評論 |
作者: 是世敏吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-28 23:07:27 評論於 Review Speed: 6.0 | Submission Hit Rate: 50.0 Emphasis Research Area: Meat Experience in Analysis Sharing: None(0) 讚! | 是世敏吖 |
作者: Arlene James 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-05 17:50:40 評論於 How much will you charge? I'm a bit worried that the boss doesn't have much money and won't be able to afford it(0) 讚! | Arlene James |
作者: Otis Bloor 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-21 22:14:28 評論於 The next status is under review(0) 讚! | Otis Bloor |
作者: Tiffany Russell 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-01-26 18:22:42 評論於 I would like to know what the status of the journal is after submission. I submitted on 1.24, and it has been "new submission" for several days. How long does the "new submission" status last? What is the next status after this one?(0) 讚! | Tiffany Russell |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 23:59:56 評論於 Generally, the size of the research results and the length of the article are judged(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 17:13:47 評論於 A research article is the main type of research paper published in journals, typically longer in length and containing a large amount of research data(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 修然小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 23:43:20 評論於 How to determine the type of SCI articles?(0) 讚! | 修然小公主 |
作者: 龙鳞孝礼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 09:56:31 評論於 What does "research article" mean?(0) 讚! | 龙鳞孝礼 |
作者: 浩初超级甜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-08-12 08:18:19 評論於 Hello! ✌(̿▀̿ ̿Ĺ̯̿̿▀̿ ̿)✌ Would you please clarify if the disclosure of interests for this magazine should be submitted by the corresponding author only, or if each author needs to submit their own?(0) 讚! | 浩初超级甜 |
作者: 阳羽酱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-06-28 20:37:44 評論於 Please translate the following paragraph into English and Japanese, and use ":" and ":" as headers(0) 讚! | 阳羽酱 |
作者: 努力啊大慕易 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-06-11 18:31:56 評論於 Major repair or minor repair?(0) 讚! | 努力啊大慕易 |
作者: 阳羽酱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-04-20 08:03:47 評論於 Review speed: 1.0 | Submission acceptance rate: 50.0 Sharing of experience: Around one month for the first review, acceptance within 20 days after revision, very fast(0) 讚! | 阳羽酱 |
作者: 云来思若 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-10-05 22:26:47 評論於 Submitted a manuscript for review, but haven't received any response for a long time, so finally withdrew it(0) 讚! | 云来思若 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-07-01 20:12:20 評論於 It's too unpredictable, it fell a little bit more than last year, I wonder if we can maintain a 3-point lead next year, it feels unreliable(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-06-29 12:09:22 評論於 The outlook is positive, if it rises a bit more tomorrow, it may break the 3-point mark(0) 讚! | 凌霄高洁 |
作者: 匿名 領域: 生命科学 審稿時間: 0.0 month(s) 結果: 撰寫評論 |
2011-06-08 15:08:00 評論於 The manuscript was reviewed several times, and the experiment was supplemented with additional material. It took nearly three months for acceptance. (0) 讚! | 匿名 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us